Implication of the INK4a/ARF Locus in Gastroenteropancreatic Neuroendocrine Tumorigenesis
Authors:
- 1 April 2004
- journal article
- review article
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 1014 (1) , 284-299
Abstract
Abstract: The INK4a/ARF locus on chromosome 9p21 is one of the important defenses against tumor development and engages both the Rb and the p53 tumor suppressor pathways through its capacity to encode two distinct proteins, p16INK4a and p14ARF. Despite controversial reports, the body of present data suggests that tumor suppressors p16INK4a and p14ARF are targets of in‐activation in GEP‐NETs. Moreover, tumor type‐specific aberrant p16INK4a silencing appears to be associated with advanced tumor stage and may function as a predictor of patients' outcome after surgical resection. Since conventional histological and biochemical assessment are limited with respect to predicting GEP‐NET behavior or outcome, methylation profiles including INK4a/ARF might offer a tool to refine future diagnosis and therapeutic management of GEP‐NET patients.Keywords
This publication has 49 references indexed in Scilit:
- Transcriptional Coactivator Cited2 Induces Bmi1 and Mel18 and Controls Fibroblast Proliferation viaInk4a/ARFMolecular and Cellular Biology, 2003
- Aberrant Hypermethylation of Tumor Suppressor Genes in Pancreatic Endocrine NeoplasmsAnnals of Surgery, 2003
- Genetic alterations in poorly differentiated endocrine carcinomas of the gastrointestinal tractCancer, 2003
- CDKN2A point mutations D153spl(c.457G>T) and IVS2+1G>T result in aberrant splice products affecting both p16INK4a and p14ARFOncogene, 2003
- Acute mutation of retinoblastoma gene function is sufficient for cell cycle re-entryNature, 2003
- Frequent RASSF1A promoter hypermethylation and K-ras mutations in pancreatic carcinomaOncogene, 2003
- Peculiar structure and location of 9p21 homozygous deletion breakpoints in human cancer cellsGenes, Chromosomes and Cancer, 2003
- Parsing Ink4a/ArfCell, 2001
- twist is a potential oncogene that inhibits apoptosisGenes & Development, 1999
- Characterisation of Neuroendocrine Tumors in Transgenic MiceDigestion, 1994